Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities

Area of Science:

• Oncology
• Gastroenterology
• Natural Product Chemistry

Background:

• Digestive system cancers, particularly colorectal and gastric malignancies, are leading causes of cancer-related deaths globally.
• Epidemiological studies suggest that consuming allium-containing foods, such as garlic, is associated with a reduced risk of developing these cancers.
• Allicin, a key sulfur-containing compound in garlic, degrades into various bioactive compounds like diallyl sulfide (DAS), diallyl trisulfide (DATS), and diallyl disulfide (DADS) within the gastric environment.

Purpose of the Study:

• To summarize the therapeutic potential of allicin and its derived compounds in the context of treating gastrointestinal (GI) cancers.
• To highlight the anticancer efficacy of allicin-derived substances against various cancer types, including GI malignancies.
• To provide an overview of the scientific literature on allicin's role in cancer chemoprevention and therapy.

Main Methods:

• Literature review of epidemiological studies on garlic consumption and cancer risk.
• Analysis of research on the chemical composition and degradation products of allicin.
• Compilation of evidence regarding the anticancer, anti-inflammatory, and other health benefits of allicin and its sulfur-containing derivatives.
• Focus on studies investigating the efficacy of these compounds against gastrointestinal cancers.

Main Results:

• Allicin and its degradation products (DAS, DATS, DADS) possess a broad spectrum of biological activities, including anticancer, anti-inflammatory, antibacterial, antiviral, and antifungal properties.
• These sulfur-containing compounds have demonstrated significant efficacy against various cancers, notably GI cancers, leukemia, and skin cancers.
• The anti-cancer mechanisms are linked to their ability to induce apoptosis, inhibit proliferation, and modulate signaling pathways crucial for cancer development.

Conclusions:

• Allicin and its derivatives represent a promising natural therapeutic agent for the prevention and treatment of digestive system cancers.
• Further research into the specific mechanisms and clinical applications of allicin is warranted to fully exploit its potential in oncology.
• Dietary intake of garlic and its active compounds may contribute to reducing the burden of gastrointestinal malignancies.